BLIRT visits Medlab Middle East to connect with innovation, changing the face of diagnostics.

Among the leading companies influencing the latest technological achievements, there could be no shortage of a well-established recombinant enzyme for the Life Science Industry produced by BLIRT.

BLIRT manufactures reagents used in nucleic acid-based diagnostic tests, such as RT-qPCR, RT-LAMP, and in situ sequencing, a relatively novel method used in cancer detection.

Ours’ enzyme portfolio includes reagents needed for sample preparation with Proteinase K, RNA or DNA isolation with dedicated kits, specific nucleases, the reverse transcription reaction run by TranscriptMe reverse transcriptase, and subsequent DNA amplification processed by the AmplifyMe sets.

Check the benefits you will gain by working with us and book a meeting with our representatives.